Biomerieux SA

BIM.PA · Moat type: UNBESTIMMT
MoatScore
4/10
Fair Value
60 EUR (≈ 67.97 USD)
Margin of Safety
-17.9 %
Rating
BEOBACHTEN
bioMérieux develops, produces and distributes in vitro diagnostic solutions – primarily microbiological test systems and reagents for clinical diagnostics, food safety and industry – and generates recurring revenues primarily through the continuous consumption of reagents and consumables on installed analysis equipment.
View full analysis →
🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.